Gerald G. Krueger

Biology of Langerhans cells: selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice.

Impact of obesity and smoking on psoriasis presentation and management.

Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes.

A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.

Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking.

Multiple Loci within the major histocompatibility complex confer risk of psoriasis.

Obesity in early adulthood as a risk factor for psoriatic arthritis.

Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients.

Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL.

Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis.

Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.

Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis.

Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.

Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.

Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.

Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--reply.

Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis.

Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.

Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.

Desired Improvement Tool (DIT): A tool to assess desire for improvement in psoriasis patients.

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.

The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA.

Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial.

PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries.